Cargando…

Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial

BACKGROUND: The aim of this trial was to assess the relative efficacy of a sage/echinacea spray and a chlorhexidine/lidocaine spray in the treatment of acute sore throats. METHODS: This was a multicenter, randomized, double-blind, double-dummy controlled trial carried out in eleven general practices...

Descripción completa

Detalles Bibliográficos
Autores principales: Schapowal, A, Berger, D, Klein, P, Suter, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351972/
https://www.ncbi.nlm.nih.gov/pubmed/19748859
http://dx.doi.org/10.1186/2047-783X-14-9-406
_version_ 1782232820962295808
author Schapowal, A
Berger, D
Klein, P
Suter, A
author_facet Schapowal, A
Berger, D
Klein, P
Suter, A
author_sort Schapowal, A
collection PubMed
description BACKGROUND: The aim of this trial was to assess the relative efficacy of a sage/echinacea spray and a chlorhexidine/lidocaine spray in the treatment of acute sore throats. METHODS: This was a multicenter, randomized, double-blind, double-dummy controlled trial carried out in eleven general practices in Switzerland. A total of 154 patients (133 analyzed in per protocol collective) at least 12 years old with acute sore throat present for not more than 72 hours prior to inclusion and with a throat score ≥6 participated in the study. They used either an echinacea/sage spray or a chlorhexidine/lidocaine spray with two puffs every 2 hours, in a double-dummy blinded manner, up to 10 times daily until they were symptom-free, for a maximum of 5 days. The main outcome measures was the comparison of response rates during the first three days. A response was defined as a decrease of at least 50% of the total symptoms compared to baseline. RESULTS: The echinacea/sage treatment exhibited similar efficacy to the chlorhexidine/lidocaine treatment in reducing sore throat symptoms during the first 3 days (P(x < Y) = .5083). Response rates after 3 days were 63.8% in the echinacea/sage group and 57.8% in the chlorhexidine/lidocaine group. For all secondary parameters, such as time to becoming symptom free, throat pain, and global assessments of efficacy by the physician and patient, no difference between the two treatments was seen. They were both very well tolerated. CONCLUSION: An echinacea/sage preparation is as efficacious and well tolerated as a chlorhexidine/lidocaine spray in the treatment of acute sore throats.
format Online
Article
Text
id pubmed-3351972
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33519722012-05-16 Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial Schapowal, A Berger, D Klein, P Suter, A Eur J Med Res Research BACKGROUND: The aim of this trial was to assess the relative efficacy of a sage/echinacea spray and a chlorhexidine/lidocaine spray in the treatment of acute sore throats. METHODS: This was a multicenter, randomized, double-blind, double-dummy controlled trial carried out in eleven general practices in Switzerland. A total of 154 patients (133 analyzed in per protocol collective) at least 12 years old with acute sore throat present for not more than 72 hours prior to inclusion and with a throat score ≥6 participated in the study. They used either an echinacea/sage spray or a chlorhexidine/lidocaine spray with two puffs every 2 hours, in a double-dummy blinded manner, up to 10 times daily until they were symptom-free, for a maximum of 5 days. The main outcome measures was the comparison of response rates during the first three days. A response was defined as a decrease of at least 50% of the total symptoms compared to baseline. RESULTS: The echinacea/sage treatment exhibited similar efficacy to the chlorhexidine/lidocaine treatment in reducing sore throat symptoms during the first 3 days (P(x < Y) = .5083). Response rates after 3 days were 63.8% in the echinacea/sage group and 57.8% in the chlorhexidine/lidocaine group. For all secondary parameters, such as time to becoming symptom free, throat pain, and global assessments of efficacy by the physician and patient, no difference between the two treatments was seen. They were both very well tolerated. CONCLUSION: An echinacea/sage preparation is as efficacious and well tolerated as a chlorhexidine/lidocaine spray in the treatment of acute sore throats. BioMed Central 2009-09-01 /pmc/articles/PMC3351972/ /pubmed/19748859 http://dx.doi.org/10.1186/2047-783X-14-9-406 Text en Copyright ©2009 I. Holzapfel Publishers
spellingShingle Research
Schapowal, A
Berger, D
Klein, P
Suter, A
Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial
title Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial
title_full Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial
title_fullStr Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial
title_full_unstemmed Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial
title_short Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial
title_sort echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351972/
https://www.ncbi.nlm.nih.gov/pubmed/19748859
http://dx.doi.org/10.1186/2047-783X-14-9-406
work_keys_str_mv AT schapowala echinaceasageorchlorhexidinelidocainefortreatingacutesorethroatsarandomizeddoubleblindtrial
AT bergerd echinaceasageorchlorhexidinelidocainefortreatingacutesorethroatsarandomizeddoubleblindtrial
AT kleinp echinaceasageorchlorhexidinelidocainefortreatingacutesorethroatsarandomizeddoubleblindtrial
AT sutera echinaceasageorchlorhexidinelidocainefortreatingacutesorethroatsarandomizeddoubleblindtrial